Premium
Disseminated Bacille Calmette‐Guérin infection in a patient with severe combined immunodeficiency caused by JAK3 gene mutation
Author(s) -
Li Meiyun,
Chen Zhuo,
Zhu Yunlu,
Chen Ji
Publication year - 2019
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13884
Subject(s) - medicine , severe combined immunodeficiency , immunodeficiency , vaccination , mycobacterium bovis , immunology , tuberculosis , primary immunodeficiency , attenuated vaccine , mycobacterium tuberculosis , bcg vaccine , immunity , virology , immune system , gene , pathology , biology , virulence , biochemistry
Bacille Calmette‐Guérin (BCG), a live attenuated vaccine prepared using Mycobacterium bovis , can prevent tuberculosis in children and is routinely administered to infants in China and many other countries. A serious complication following vaccination is disseminated BCG infection. The risk is greatly increased in patients with severe combined immunodeficiency disease (SCID), a syndrome characterized by deficiency of both humoral and cellular immunity. We report a case of disseminated BCG infection in an infant with SCID caused by two novel janus kinase 3 ( JAK3 ) gene mutations.